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Mediated by binding to the high-aﬃnity vitamin D receptor (VDR), vitamin D forms a heterodimer complex with the retinoid-
X-receptor (RXR). Variation in both genes has been shown to modify renal cell carcinoma (RCC) risk. Therefore, we investigated
whether VDR and RXRA polymorphisms modify associations between RCC risk and frequency of dietary intake of vitamin D
and calcium rich foods, and occupational ultraviolet exposure among 777 RCC case and 1035 controls from Central and Eastern
Europe. A positive association was observed in this population between increasing dietary intake frequency of yogurt, while an
inverse association was observed with egg intake frequency. RXRA polymorphisms, located 3  of the coding sequence, modiﬁed
associationsbetweenspeciﬁcvitaminDrichfoodsandRCCrisk,whileRXRApolymorphisms,locatedinintrons1and4,modiﬁed
associations with speciﬁc calcium rich foods. Results suggest that variants in the RXRA gene modiﬁed the associations observed
between RCC risk and calcium and vitamin D intake.
1.Introduction
Smoking, obesity, and hypertension are well-established risk
factors of renal cell carcinoma (RCC) [1, 2]. Other risk fac-
tors such as dietary practices have been implicated, though
inconsistent results have usually been reported for speciﬁc
dietary components [1, 3]. Diets rich in fruits and vegetables
however have typically been shown to decrease RCC risk
possibly through antioxidant eﬀects, while consumption
of fried foods has commonly been shown to increase
risk possibly due to the potential carcinogenic eﬀects of
acrylamides [1–3]. Recently, epidemiological studies suggest
that vitamin D, which is found in food (vitamin D2 and D3)
and produced in the body after exposure to ultraviolet (UV)
rays from the sun (vitamin D3), may be inversely associated
with RCC risk [4–7].
Both vitamin D2 and D3 are hydroxylated in the liver
and subsequently in the kidney to form active vitamin D
(1,25(OH)2D3)[ 8]. Dietary intake of vitamin D accounts
for a small (approximately 10%) proportion of vitamin D
levels [8–10]. However, dietary intake of vitamin D and
vitaminDrichfoodsmayplayaroleindeterminingRCCrisk
since vitamin D has been associated with anticarcinogenic
properties and is primarily metabolized within the kidneys
[8, 11].
Although the exact anticarcinogenic mechanism of vita-
min D is not fully understood, vitamin D and its metabolites2 International Journal of Endocrinology
are thought to impede carcinogenesis by stimulating cell dif-
ferentiation,inhibitingcellproliferation,inducingapoptosis,
and suppressing invasiveness, angiogenesis, and metastasis
[11–14]. Vitamin D is mediated by binding to vitamin D
receptors (VDRs), transcription factors that are part of the
nuclear hormone receptor family. Forming a heterodimer
complex with the retinoid-X-receptor (RXR)g e n e ,VDR
can regulate the transcription of other genes involved in
cell regulation, growth, and immunity [13, 15, 16]. Most
epidemiological studies have generally focused on the VDR
gene, however recently, we evaluated 139 single nucleotide
polymorphisms (SNPs) across eight genes of the vitamin D
pathway and found a signiﬁcant association between RCC
risk and across certain VDR and RXRA genetic variants [17].
Given that the kidney is the most important organ for
vitamin D metabolism and activity and calcium homeostasis
and that within the kidneys, calcium has been shown to
inﬂuence active vitamin D levels [8, 17], investigation of
dietary vitamin D and calcium in RCC etiology are highly
relevant. We therefore investigated whether common genetic
variationinVDRandRXRA,thetwogenesweobservedtobe
signiﬁcantly associated with RCC risk, modiﬁed associations
between renal cancer risk and the frequency of dietary intake
of vitamin D and calcium rich foods. Additionally, we also
explored whether these genes modiﬁed occupational UV
exposure and RCC risk, since recently we reported a signiﬁ-
cant inverse association between occupational UV exposure
and RCC risk among male participants in this population
[18] and because the majority of people worldwide obtain
most of their vitamin D levels from the sun [8–10]. Analyses
were conducted among cases and controls from Central and
Eastern Europe, an area with one of the highest rates of RCC
worldwideandanareawherefoodsarenotregularlyfortiﬁed
with either vitamin D or calcium [19].
2.MaterialsandMethods
2.1. Study Population. Details regarding this study popu-
lation were previously described [20]. Brieﬂy, from 1999
through 2003, a hospital-based case-control study of RCC
was conducted in seven centers in four countries of Central
and Eastern Europe (Moscow, Russia; Bucharest, Romania;
Lodz, Poland; Prague, Olomouc, Ceske-Budejovice, and
Brno, Czech Republic). Cases, 20 to 88 years of age,
included newly diagnosed patients (within 3 months) with
histologically conﬁrmed RCC (IDC-O-2 codes C64) who
resided in the study areas for at least one year. Controls
in all centers were frequency matched to cases on age (±3
years), sex, and place of residence. Controls were chosen
among subjects admitted as inpatients or out patients in
the same hospital as the cases, with non-tobacco-related
conditions,includinginfections(1.1%),hematologic(3.2%),
endocrine (2.0%), psychiatric (1.4%), neurologic (11.2%),
ophthalmologic or otologic (14.5%), cardiovascular (9.6%),
pulmonary (3.9%), gastrointestinal (18.7%), dermatologic
(2.8%), orthopedic or rheumatologic (8.9%), genitourinary
(benign prostatic hyperplasia) (3.8%), obstetric or perinatal
(0.1%), injury or poisoning (3.0%), and other (15.9%). No
single disease made up more than 20% of the control group.
Furthermore, a number of controls were also recruited in
parallel for studies of lung and head and neck cancers
[21, 22]. A total of 1097 incident, histologically conﬁrmed
RCC cases and 1476 controls were included in this study.
Suitable quantity and quality of genomic DNA was obtained
from a subset of 777 (70.8%) eligible RCC cases and 1035
(70.1%) controls enrolled in our study. The response rates
across study centers for study participation ranged from
90.0% to 98.6% for cases and from 90.3% to 96.1% for
controls. All subjects provided written informed consent.
This study was approved by the institutional review boards
of all participating centers.
2.2. Dietary Intake. Details of dietary assessment have been
previously described [23]. Brieﬂy, interviewers were trained
in each center to perform face-to-face interviews with
cases and controls during hospitalization using standard
questionnaires. The questionnaire covered demographic
characteristics, family history of cancer, history of tobacco
consumption, and dietary habits. A food frequency ques-
tionnaire was comprised of 23 food items, which the study
investigators selected by consensus during the planning stage
of the study and further validated during the pilot stage by
asking participants to name common food items not already
speciﬁed [23]. Frequency of dietary intake for each food
group was assessed for each item as never, less than once
per month, less than once per week, one to two times per
week, three to ﬁve times per week, and daily. A standardized
questionnaire was used in each of the study centers that
was translated from a common English version and then
backtranslatedintoEnglishtoensurethevalidityoftheinitial
translation. The questionnaire was repeated for two diﬀerent
time periods: (1) the year prior to interview, and (2) the
year prior to political and market changes in 1989 (1991 in
Russia). Data for the year prior to interview and the year
prior to political change were then extrapolated to represent
lifetime average dietary intake by multiplying the score for
each time period by the number of years the participant
was alive during the time period, then summing the time
period scores and dividing by the total age of the individual
as previously described.
In this study, intake frequencies of vitamin D rich foods
which include liver, eggs, and ﬁsh were combined for each
participant to create a new dietary exposure variable for
total vitamin D intake frequency. Since calcium has been
reported to inﬂuence vitamin D levels and risk of certain
cancers [8], intake frequencies of cheese, milk, and yogurt
were also combined for each participant to create a new total
calcium intake frequency exposure variable. In this study,
speciﬁc details regarding the type of ﬁsh, cheese, milk, and
so forth consumed was not available; therefore, each food
category was assumed to have equal weights when combined
to estimate total vitamin D or total calcium lifetime average
dietary intake frequency. Very few foods naturally contain
vitamin D and in the United States (US) and Canada,
fortiﬁed foods are common sources of vitamin D [8, 9].
However, in most countries, such as those in Central andInternational Journal of Endocrinology 3
Table 1: General characteristics of genotyped participants.
Genotyped participants
Variables Cases Controls
N% N% †P-value
Participants 777 42.9 1,035 57.1
Sex
Males 472 60.7 648 62.6
Females 305 39.3 387 37.4 .42
Age at Interview
<45 60 7.7 83 8.0
45–54 197 25.4 287 27.7
55–64 243 31.3 309 29.9
65–74 242 31.1 318 30.7
75+ 35 4.5 38 3.7 .30
Mean age (std) 59.5 years (10.4) 59.0 years (10.2)
Center
Romania-Bucharest 68 8.8 94 9.1
Poland-Lodz 80 10.3 189 18.3
Russia-Moscow 242 31.1 313 30.2
∗Czech Republic 387 49.8 439 42.4 <.001
BMI at Interview
<25 222 28.6 375 36.3
25–29.9 330 42.5 432 41.9
30+ 225 29.0 225 21.8 <.001
Tobacco status
Never 359 46.4 420 40.7
Ever 415 53.6 613 59.3 .02
Hypertension
No 434 55.9 638 61.7
Yes 342 44.1 396 38.3 .01
Familial history of cancer
Among 1st degree relatives
No 512 65.9 745 72.0
Yes 265 34.1 290 28.0 .01
∗ Brno, Olomouc, Prague, Ceske-Budejovice; †Crude P-values.
Eastern Europe, foods are not fortiﬁed with vitamin D or
calcium. Therefore the major sources of vitamin D intake
are fatty ﬁsh, such as mackerel and salmon, while the main
source of calcium intake is primarily dairy products [7–9].
All dietary intake frequencies in this study were assessed
in tertiles based on the frequency of dietary intake among
controls.
2.3. OccupationalUV Exposure. Lifetime occupational infor-
mation for jobs held for at least 12 months duration
was also ascertained during interviews through the use
of a general occupational questionnaire. Data collected
for each job included title, detailed tasks, and type of
employer as well as the year of beginning and ending
employment. These data were used to create a job-exposure
matrix (JEM) which classiﬁed each study subjects’ estimated
occupational exposure to sunlight; the JEM is described
in more detail elsewhere [18]. To assess the relationship
between estimated occupational sunlight exposure, RCC
risk and variation in vitamin D pathway genes, cumulative
exposure across all jobs (calculated as duration (years) x
frequency midpoint x intensity of exposure for each job
and summed over all jobs held) was assessed. Since the
association between occupational UV exposure and RCC
risk in this population was previously observed only among
males [18], evaluation of genetic variants, occupational
UV exposure, and RCC risk are only presented for male
participants. The relationship between these exposures and
RCC risk was also explored among female participants;
however no association was observed (data not shown).4 International Journal of Endocrinology
Table 2: RCC risk by dietary intake frequency of vitamin D and calcium rich foods among genotyped participants.
Cases Controls Adjusted
Intake Frequency N % N % OR UCI — LCI P-trend
Liver
Low (<33%) 318 41.0 411 39.7 1.00
Medium (33–66%) 315 40.6 380 36.7 1.11 0.89 — 1.38
High (>66%) 143 18.4 244 23.6 0.82 0.63 — 1.07 .28
Egg
Low (<33%) 274 35.3 345 33.3 1.00
Medium (33–66%) 392 50.5 454 43.9 1.11 0.90 — 1.38
High (>66%) 110 14.2 236 22.8 0.64 0.48 — 0.86 .02
Fresh Water Fish
Low (<33%) 260 33.5 345 33.3 1.00
Medium (33–66%) 274 35.3 344 33.2 1.06 0.84 — 1.34
High (>66%) 242 31.2 346 33.4 0.94 0.74 — 1.19 .60
Salt Water Fish
Low (<33%) 259 33.4 346 33.4 1.00
Medium (33–66%) 334 43.0 419 40.5 1.02 0.82 — 1.27
High (>66%) 183 23.6 270 26.1 0.91 0.71 — 1.18 .53
Total Fish
Low (<33%) 290 37.4 380 36.7 1.00
Medium (33–66%) 236 30.4 309 29.9 0.98 0.77 — 1.23
High (>66%) 250 32.2 346 33.4 0.95 0.75 — 1.19 .65
Total Vitamin D
Low (<33%) 284 36.6 345 33.3 1.00
Medium (33–66%) 279 36.0 353 34.1 0.95 0.76 — 1.20
High (>66%) 213 27.4 337 32.6 0.81 0.63 — 1.03 .09
Cheese
Low (<33%) 193 24.9 286 27.6 1.00
Medium (33–66%) 302 38.9 337 32.6 1.31 1.03 — 1.68
High (>66%) 281 36.2 412 39.8 0.99 0.77 — 1.26 .71
Yogurt
Low (<33%) 202 26.0 347 33.5 1.00
Medium (33–66%) 278 35.8 313 30.2 1.48 1.16 — 1.88
High (>66%) 296 38.1 375 36.2 1.31 1.03 — 1.67 .04
Milk
Low (<33%) 179 23.1 264 25.5 1.00
Medium (33–66%) 292 37.6 389 37.6 1.10 0.86 — 1.42
High (>66%) 305 39.3 382 36.9 1.14 0.89 — 1.46 .31
∗Total Calcium
Low (<33%) 226 29.1 345 33.3 1.00
Medium (33–66%) 274 35.3 355 34.3 1.16 0.91 — 1.48
High (>66%) 276 35.6 335 32.4 1.20 0.92 — 1.58 .18
All values adjusted for sex, age, study center, self-reported hypertensive status, BMI, and smoking status.
Frequency of dietary intake variables categorized into tertiles based on intake among genotypes controls.
Total Vitamin D (L, M, H) variable based on liver, egg, and salt and fresh water ﬁsh consumption.
Also adjusted for years of occupational UV exposure.
∗ Total calcium variable based on cheese, yogurt, and milk consumption.
A categorical exposure matrix was used to evaluate the
association between RCC risk and cumulative occupational
UV exposure based on tertiles of exposure levels among male
controls.
2.4. Laboratory Procedures. Genomic DNA was extracted
from whole blood buﬀy coat using a standard phenol
chloroform method at the National Cancer Institute (NCI)
laboratory. Genotyping was conducted with a GoldenGateInternational Journal of Endocrinology 5
OligoPoolAll(OPA)assaybyIllumina(www.illumina.com).
DNA samples from RCC cases and controls were coded and
randomized on polymerase chain reaction (PCR) plates for
genotyping analyses. A random 5% duplicate sample was
selected and dispensed across plates genotyped for quality
control.
As previously reported in this population [17], the
ten SNPS across the VDR gene (rs11574027, rs4760648,
rs2853564, rs2254210, and rs886441) and RXRA gene
(rs100791,rs3118523,rs748964,rs3118536,andrs10776909)
that were signiﬁcantly associated with RCC risk were
further evaluated in this study to see if SNPs modiﬁed
associations between RCC risk and dietary or occupational
UV exposure. Tag SNPs were originally selected to pro-
vide 80% to 90% coverage across the genomic regions of
interest and were applicable, while nonsynonymous SNPs
were selected for their putative functional signiﬁcance. All
SNPs selected for analysis had a variant allele frequency
of at least 5% as reported by the NCI SNP500Cancer
Database (http://snp500cancer.nci.nih.gov)[ 24] and had
a validated assay at the NCI Core Genotyping Facility
(CGF) (http://cgf.nci.nih.gov/home.cfm). The concordance
rate between duplicate DNA samples ranged from 93% to
100% and completion rates ranged from 98% to 100%. The
genotype frequencies among controls did not diﬀer from
the expected Hardy-Weinberg equilibrium proportions (P>
.05).
2.5. Statistical Analysis. The distributions of select charac-
teristics and known RCC risk factors (sex, age, smoking
habits, self-reported hypertension status, body mass index
(BMI), family history of cancer, country of residence, and
particular dietary variables) were compared between cases
and controls using the Chi-square test. Odds ratios (ORs)
and95%conﬁdenceintervals(95%CIs)usingunconditional
logistic regression were calculated to estimate the associa-
tions between individual SNPs and RCC risk.
SNP variants were assessed using a dominant model
using the Wald chi-square test for the presence or absence
of the variant allele (0, 1). Occupational UV exposure was
assessed in tertiles calculated from the exposure prevalence
among male controls. All regression models were adjusted
for age, sex, study center, smoking status (ever, never), BMI,
and self-reported hypertensive status.
VDR and RXRA haplotype blocks identiﬁed previously
[17] were analyzed in relation to RCC risk using Haplostats
(Rversion2.4.0;http://www.r-project.org)[25].Associations
b e t w e e nc o m m o nh a p l o t y p e s( >5% frequency) and RCC
risk were evaluated by computing ORs and 95% CIs using
the most common haplotype as the referent category.
Interactions were tested by comparing regression models
with and without interaction terms using a likelihood ratio
test (LRT). Interactions between dietary components, select
VDR and RXRA SNPs, and RCC risk were only assessed for
total calcium, total vitamin D, and for intake frequency food
groups that were found to be statistically associated with
RCC risk (i.e., eggs and yogurt).
All analyses were conducted in STATA 9.0 unless other-
wise speciﬁed (STATA Corporation, College Station, TX).
3. Results
Table 1 provides a description of genotyped study partici-
pants and known RCC risk factors. Cases and controls were
comparable in age and sex; however, cases were more likely
to have excess BMI (>30kg/m2), self-reported hypertension,
and have a ﬁrst degree relative with cancer. After adjustment
for age, BMI, hypertension, study center, and sex the
association with smoking was no longer observed [26].
Associations between intake frequency of vitamin D
and calcium rich foods and RCC risk among genotyped
participants are shown in Table 2. A statistically signiﬁcant
reduction in RCC risk was observed with increasing con-
sumption frequency of eggs (P-trend = .02). A borderline
statistically signiﬁcant reduction in RCC risk was observed
with increasing consumption frequency of total vitamin D
(P-trend=.09).Incontrast,increasedRCCriskwasobserved
with increasing consumption frequency of yogurt (P-trend =
.04).
Associations between RCC risk, RXRA SNPs, and intake
frequency of eggs and total vitamin D are shown in
Table 3. Inverse associations were observed between RCC
risk and subjects with the wild type rs1007971 (P-trend
= .05), rs3118523 (P-trend = .01), rs748964 (P-trend =
.01), rs3118536 (P-trend = .02), and rs10776909 (P-trend
= .05) RXRA genotypes compared to individuals with at
least 1 variant allele. However, after stratiﬁcation by egg
intake, reduced RCC risk was observed with increasing
consumption frequency of eggs among subjects with ≥1
variant rs1007971 (P-trend <. 001), rs3118523 (P-trend <
.001), rs748964 (P-trend <. 001), rs3118536 (P-trend <
.001), and rs10776909 (P-trend = .004) allele across the
RXRA gene. Interactions were only signiﬁcant for RXRA
SNPs located downstream, 3  of the coding sequence that
is, rs1007971 (P-interaction = .01), rs3118523 (P-interaction
= .01), and rs748964 (P-interaction = .01). Although not
statistically signiﬁcant, a weaker inverse association between
RCC risk and total vitamin D (based on liver, eggs, and ﬁsh)
intake frequency was observed. No association was observed
between any of the VDR SNPs and dietary consumption
frequency of eggs or total vitamin D (data not shown).
Associations between RCC risk, RXRA SNPs, and intake
frequency of yogurt and total calcium are shown in Table 4.
A positive association was observed between RCC risk
and increasing consumption frequency of yogurt among
participants with the wild type CC rs3118538 (P-trend =
.01) and CC rs10776909 (P-trend = .01) alleles across the
RXRA gene; rs10776909 located in intron 1 was also shown
to signiﬁcantly modify associations between frequency of
dietary intake of yogurt and RCC risk (P-interaction = .04).
Similarly, increased RCC risk was observed with increasing
total calcium intake frequency for subjects with the wild
type CC rs3118538 (P-trend = .05) and CC rs10776909 (P-
trend = .02) alleles. Signiﬁcant interactions were observed
for both SNPs, located in introns 1 and 4, within the RXRA6 International Journal of Endocrinology
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Table 4: Eﬀect of RXRA SNPs on dietary intake frequency of calcium rich foods and risk of renal cell carcinoma.
rs3118538 (IVS4-542C > A) rs10776909 (IVS1-4732C > T)
Wild type ≥1 variant Wild type ≥1 variant
Cases/Controls Cases/Controls Cases/Controls Cases/Controls
N/N OR (UCI-LCI) N/N OR (UCI-LCI) ∗LRT N/N OR (UCI-LCI) N/N OR (UCI-LCI) ∗LRT
Dietary Intake of
Yogurt
Low (<33%) 133/266 1.00 77/91 1.00 123/247 1.00 87/110 1.00
Medium (33–66%)185/212 1.88 (1.34–2.64) 85/91 1.23 (0.73–2.08) 169/198 1.84 (1.29–2.63) 101/105 1.29 (0.81–2.07)
High (>66%) 199/247 1.69 (1.18–2.42) 97/128 0.87 (0.51–1.50) 182/218 1.71 (1.18–2.49) 114/157 0.94 (0.58–1.54)
P-trend .01 .41 .01 .58
.09 .04
Dietary Intake of
Calcium Rich
Foods
Low (<33%) 146/248 1.00 80/97 1.00 135/236 1.00 91/109 1.00
Medium (33–66%)180/261 1.18 (0.88–1.59) 94/94 1.22 (0.78–1.89) 162/238 1.21 (0.89–1.66) 112/117 1.10 (0.73–1.64)
High (>66%) 191/216 1.39 (1.00–1.93) 85/119 0.76 (0.47–1.22) 177/189 1.49 (1.06–2.11) 99/146 0.73 (0.47–1.14)
P-trend .05 .25 .02 .16
.03 .02
Dietary eﬀect adjusted for age, sex, study center, BMI, self-reported hypertensive status, and smoking status.
Frequency of dietary intake variables categorized into tertiles based on intake among genotyped controls.
Calcium rich foods based on consumption of cheese, yogurt, and milk.
Main eﬀects adjusted for age, sex, study center, and smoking status.
rs3118538 (IVS4-542C > A) main eﬀects: AC (0.68(0.39–1.18)), AA (0.58(0.34–0.99)), P-trend = .02; AC/AA (0.82(0.67–1.00)).
rs10776909 (IVS1-4732C > T) main eﬀects: CT (0.69(0.42–1.13)), TT (0.62(0.38–1.00)), P-trend = .05; CT/TT (0.86(0.70–1.04)).
∗Likelihood Ratio Test.
gene. No association was observed between intake frequency
of yogurt or total calcium and the other SNPs (N = 8)
previouslyshowntobeassociatedwithRCCriskinthisstudy
[17].
Previously we observed a signiﬁcant reduction (38%) in
RCC risk among male participants occupational exposed to
UV [18]. In this study, neither VDR nor RXRA SNPs mod-
iﬁed the observed associations (data not shown); however,
certain VDR haplotypes, previously associated with RCC
risk in this study [18], were found to modify associations
between RCC risk and occupational UV exposure among
male participants (Table 5). Males with the VDR A-G-C
(rs2254210, rs2853564, and rs4760648) haplotype were at a
signiﬁcantly increased (OR = 1.27; 95%CI = 1.03–1.57) risk
of renal cancer compared to males with the most common
referent haplotype G-A-T. When haplotypes were stratiﬁed
by occupational UV category, only males in the highest UV
exposure category with the same VDR haplotype, A-G-C,
were shown to have a signiﬁcantly stronger increase in RCC
risk (OR = 1.70; 95%CI = 1.14–2.53) compared to males
with the referent haplotype, G-A-T. No associations between
VDR haplotypes, RCC risk and cumulative occupational
UV exposure were observed among male participants in
the lowest or middle UV category. A borderline signiﬁcant
interaction was also observed between VDR haplotypes,
occupational UV exposure, and RCC risk (P-interaction =
.06).
4. Discussion
In this study, reduced RCC risk was observed with increasing
consumption frequency of eggs while increased RCC risk
was observed with increasing consumption frequency of
yogurt. After stratiﬁcation by VDR and RXRA genotypes,
the two genes previously associated with RCC risk in this
study [17], only RXRA gene variants modiﬁed associations
between RCC risk and consumption frequency of eggs,
yogurt, and total calcium. RXRA SNPs 3  of the coding
sequence modiﬁed the association for intake frequency of
eggs while intronic RXRA SNPS modiﬁed the association
for intake frequency of yogurt and total calcium. No
associations with VDR or RXRA g e n o t y p e sw e r eo b s e r v e d
with occupational UV exposure and RCC risk among male
participantspreviouslyobservedtohavelowerRCCriskwith
increasing occupational sunlight exposure [18]; however,
when VDR haplotypes were examined male subjects in the
highest cumulative occupational UV exposure category with
the A-G-C VDR haplotype had a signiﬁcant increase in RCC
risk compared to male subjects with the referent G-A-T
haplotype.
Numerous studies have established a link between diet
and cancer risk or progression, therefore the World Cancer
Research Fund has recently acknowledged that after smok-
ing, diet may be the second most important contributor to
the global burden of cancer [27]. While, dietary vitamin
D intake constitutes a small proportion of total vitamin D8 International Journal of Endocrinology
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requirements [8, 9], studies suggest that dietary intake of
vitamin D may play an important role in determining cancer
risk [5, 28]. This is particularly important in areas where
ultraviolet levels of exposure vary seasonally. Overall, most
epidemiologicalstudiesinvestigatingtheassociationbetween
RCC risk and vitamin D or calcium rich foods have been
inconsistent and generally null [23, 28–32]. Similar to the
results we present in this study, an Italian case-control study
of 767 RCC cases and 1534 controls observed a signiﬁcant
inverse association between dietary vitamin D intake, based
on a 78-item food frequency questionnaire, and RCC risk
[5]. However, an earlier Canadian RCC case-control study
showed no association for intake of individual foods rich in
vitamin D (i.e., ﬁsh and eggs) or calcium (i.e., milk, diary,
and cheese) [28]. In contrast, calcium supplement intake in
that study was shown to signiﬁcantly reduce RCC risk with
increasing the number of years of intake [28].
Whilenoreportstodatehaveinvestigatedtheassociation
between RCC risk, dietary intake of vitamin D or calcium
rich foods, and vitamin D gene variants, results have been
reported for VDR SNPs and other cancers. For example,
two colorectal case-control studies, one in the US [33]
and one in UK [34], observed reduced cancer risk with
increasingintakeofvitaminDandcalciumrichfoodsamong
participantswiththehomozygousVDRvariant(polyA,BsmI,
and/or ApaI) alleles compared to participants with the wild
type alleles. In contrast, a US case-control study reported
increased colorectal cancer risk with increasing vitamin D
intake for subjects with the homozygous variant VDR (BsmI
BB)a l l e l e[ 35]. No association between vitamin D intake,
VDR polymorphisms (TaqI, BsmI, FokI, ApaI, and/or polyA)
andlymphoma[36]andbreastcancerrisk[37],wasreported
in two separate US studies.
Epidemiological studies investigating whether polymor-
phisms in vitamin D pathway genes modify the relationship
betweencancerriskandUVexposurehavebeeninconsistent.
Similar to our results, an association between UV exposure
and VDR haplotypes comprised of the rs2254210 SNP was
reported in a recent British prostate cancer case-control
study. Four VDR SNPs in two haplotype block regions were
shown to signiﬁcantly increase cancer risk among men with
low UV exposure [38]. However, inverse associations were
reported in this population when ﬁve other VDR SNPs were
examinedinrelationtoUVexposureandprostatecancerrisk
[39]. Likewise, in a US case-control study of prostate cancer,
reduced cancer risk was observed among subjects with the
FokI and TaqI FFtt haplotype among subjects in the highest
UV exposure category [40].
Our study adds to the limited epidemiological evidence
that calcium and vitamin D (from dietary intake or UV
exposure), and VDR and RXRA vitamin D pathway genes
may play a role in RCC etiology. The biological activity
of vitamin D is mediated by a high-aﬃnity receptor, VDR,
which acts as a ligand-activated transcription factor that
forms a heterodimer with RXR [13, 15, 16, 41]. This VDR-
RXR heterodimer complex is directed to the vitamin D-
responsive element in the promoter region of 1,25-regulated
genes [13, 15, 16, 41]. Diﬀerent polymorphisms in the
VDR gene have been speculated to result in variation of
VDR expression and result in changes to circulating levels
of active vitamin D [4]. For this reason, epidemiological
studies suggest that tissue speciﬁc expression of vitamin D
pathway genes function as the primary mechanism involved
in linking vitamin D status with anticarcinogenic eﬀects of
1,25(OH)2D3 [42]; therefore, lower renal cancer risk may
be associated with higher circulating levels of 25(OH)D, the
storage form of vitamin D by providing substrate for renal
tissue-speciﬁc synthesis of 1,25(OH)2D3 [43]. RXRA on the
other hand may play a critical role in vitamin D activity,
particularly from dietary sources, since this gene has been
shown to regulate cholesterol [44],which is abundant in eggs
and yogurt, the food groups found statistically associated
with renal cancer risk in this study. RXRA regulated fatty
acid and cholesterol metabolism through intestinal choles-
terol absorption and bile acid synthesis [44]. Cholesterol
metabolism has been associated with arthrosclerosis which is
associated with hypertension and cardiovascular risk, known
risk factors of RCC [45].
Strengths of our study include the use of HapMap to tag
genesofinterestusinghigh(80–90%)genomiccoverageboth
5  and 3  of the target genes. This study also observed high
participation rates among newly diagnosed histologically
conﬁrmed cases and collected biologic materials from a high
proportion of subjects. The large sample size of this study
provided suﬃcient statistical power to detect relatively small
associations; however, thepower to detect gene-environment
interactions was limited and results need to be interpreted
cautiously.
Inherent limitations of our study include (1) the pos-
sibility of nondiﬀerential dietary recall bias, (2) possible
misclassiﬁcation of vitamin D and calcium intake, (3) the
inability to control for potential confounders such as total
caloric intake, which may bias results away from the null,
(4) lack of data regarding dietary vitamin D or calcium
supplements, and (5) limited statistical power for gene-
environment interactions. Additionally, 18.7% of controls
were selected among patients admitted with gastrointesti-
nal conditions, which may potentially inﬂuenced dietary
habits thus, aﬀecting study results. Limitations stemming
from the estimate of occupational UV exposure [18], such
as nondiﬀerential, inaccurate, or incomplete recall of all
occupational histories may also have biased results. While
hospital-basedcase-controlstudieshavepotentiallimitations
due to possible diﬀerences with population controls, these
studies can improve response rates for the intense collection
of biological specimens and therefore reduce the chances
of bias in the assessment of gene-environment interactions
[46]. Although there is general agreement that the serum
25(OH) vitamin D level is the best indicator of current
vitamin D status, the biochemical marker has a short half-
life and a single measurement of 25(OH) vitamin D may not
reﬂect long-term status that would be important in studies
of cancer. Moreover, vitamin D status postdiagnosis among
cases may reﬂect disease rather than historical vitamin D
levels of participants when they were healthy. Lastly, while
global P-values were assessed previously on these genes [17],
we cannot completely rule out the possibility of false positive
ﬁndings in this study due to multiple comparisons.10 International Journal of Endocrinology
In conclusion, common variants in VDR and RXRA
genes were shown to modify associations between RCC risk
and consumption frequency of vitamin D and calcium rich
foods, and occupational UV exposure. Additional studies
with large sample sizes and thorough genomic coverage
of VDR and RXRA pathway genes, suﬃciently powered to
investigate gene-environment interactions, are needed to
conﬁrm these results and to provide further insight into the
role of calcium and vitamin D in RCC etiology.
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